About Prenetics
Prenetics is a company based in Hong Kong (China) founded in 2009 by Michael M Yang and Danny Yeung. Prenetics has raised $67.65 million across 6 funding rounds from investors including David Beckham, Apis Partners and Alibaba Entrepreneurs Fund. The company has 285 employees as of December 31, 2024. Prenetics has completed 6 acquisitions, including ACT Genomics, DNAFit and Europa Sports Products. Prenetics offers products and services including CircleDNA, Insighta, ACT Genomics, and IM8. Prenetics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Hong Kong, China
- Employees 285 as on 31 Dec, 2024
- Founders Michael M Yang, Danny Yeung
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prenetics Global Limited
-
Annual Revenue
$30.62 M (USD)40.83as on Dec 31, 2024
-
Net Profit
-$46.3 M (USD)26.18as on Dec 31, 2024
-
EBITDA
-$44.96 M (USD)-0.54as on Dec 31, 2024
-
Total Equity Funding
$67.65 M (USD)
in 6 rounds
-
Latest Funding Round
$48 M (USD), Post-IPO
Oct 27, 2025
-
Investors
Apis Partners
& 19 more
-
Employee Count
285
as on Dec 31, 2024
-
Investments & Acquisitions
ACT Genomics
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Prenetics
Prenetics is a publicly listed company on the NASDAQ with ticker symbol PRE in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Prenetics
Prenetics offers a comprehensive portfolio of products and services, including CircleDNA, Insighta, ACT Genomics, and IM8.
Offers personalized DNA tests for health management and prevention.
Provides multi-cancer screening technologies for early diagnosis.
Delivers genomic profiling for solid tumor treatments.
Focuses on health supplements and wellness products for consumers.
People of Prenetics
Unlock access to complete
Unlock access to complete
Funding Insights of Prenetics
Prenetics has successfully raised a total of $67.65M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $48 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prenetics
Prenetics has secured backing from 20 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include David Beckham, Apis Partners and Alibaba Entrepreneurs Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital asset management firm
|
Locked | Locked | Locked | |
|
Capital and guidance are provided to startups for growth.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided by Beyond Ventures for startups.
|
Locked | Locked | Locked |
Investor details for Prenetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prenetics
Prenetics has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ACT Genomics, DNAFit and Europa Sports Products.
Investment portfolio details for Prenetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
End-to-end fulfillment solutions are provided to ecommerce brands by Hubmatrix.
|
Locked | Locked | 2020 | Locked | |
|
Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology.
|
Locked | Locked | 2020 | Locked | |
|
Genomics services for cancer clinical and research needs are delivered.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Prenetics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Prenetics
Detailed financials for Prenetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prenetics Comparisons
Peer comparison for Prenetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prenetics
Prenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
Detailed competitors of Prenetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prenetics
Complete news archive for Prenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prenetics
Prenetics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Prenetics is headquartered in Hong Kong, China.
Danny Yeung is the current CEO of Prenetics. They have also founded this company.
Prenetics is a funded company, having raised a total of $67.65M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Prenetics is 285.
Annual revenue of Prenetics is $30.62M as on Dec 31, 2024.
Prenetics was founded in 2009 in Hong Kong, China, within the health technology sector. An online platform is operated for genetic and diagnostic testing to identify health risks. Covid-19 PCR tests and rapid test kits have been developed, with samples analyzed via whole-genome sequencing. A DNA screening test for colon cancer detection has also been created, supporting diagnostic services in the region.
Prenetics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Prenetics offers CircleDNA, Insighta, ACT Genomics, and IM8.
Yes, Prenetics is publicly traded on NASDAQ under the ticker symbol PRE.
Prenetics has made 6 acquisitions, including ACT Genomics, DNAFit, and Europa Sports Products.
Prenetics has 20 investors. Key investors include David Beckham, Apis Partners, Alibaba Entrepreneurs Fund, Beyond Ventures, and Ping An Ventures.
The ticker symbol of Prenetics is PRE on NASDAQ.